ICD-ON Registry: Periop Management of Cardiac Devices

July 26, 2017 updated by: Janet Gifford, Edward Hospital

ICD-ON Registry: Perioperative Management of Pacemakers and Implanted Cardioverter Defibrillators

The purpose of this registry is to document incidence of electrical magnetic interference (EMI), change in programmed parameters or device related events in patients with Pacemakers (PM) and Implanted Cardioverter Defibrillators (ICDs) having surgery requiring electrocautery. A standardized perioperative device management protocol (ICD-ON Protocol) will be used.

Study Overview

Status

Completed

Detailed Description

Patients with PMs and ICDs have traditionally been considered at risk for electrical magnetic interference (EMI) from electrocautery. EMI can cause oversensing, pacing inhibition, or inappropriate ICD therapies. In July 2011, the Heart Rhythm Society /American Society of Anesthesiologists (HRS/ASA) published an Expert Consensus Statement on the perioperative management of PM and ICDs.

The purpose of this registry is to collect data on patients with PMs and ICDs undergoing procedures requiring electrocautery using a standardized device management protocol (ICD-ON Protocol). Decisions about management of patients with these devices will be made based on surgical location, programmed magnet response and pacemaker dependence.

This registry will document incidence of EMI, changes in programmed parameters or device related events associated with the procedures. Observational data will be collected on participants including: medical history, device parameters, surgical/cautery data, and postoperative device follow-up. For procedures not requiring reprogramming, postoperative PM and ICD interrogation will be either routine in office follow-up or remote monitoring, as per the subject's routine.

Study Type

Observational

Enrollment (Actual)

350

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Downers Grove, Illinois, United States, 60515
        • Advocate Good Samaritan Hospital
      • Elmhurst, Illinois, United States, 60126
        • Elmhurst Hospital
      • Naperville, Illinois, United States, 60174
        • Edward Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who have a PM or ICD undergoing procedures with anticipated electrocautery.

Description

  • Have a implanted PM or ICD
  • Be scheduled for a procedure with anticipated electrocautery
  • Be able to speak, read and understand English
  • Be willing to sign consent form

Exclusion Criteria:

  • Have an ICD from Boston Scientific under Product Advisory related to magnet performance
  • Have an ICD or PM from Biotronik or Sorin
  • Surgical procedures with two or more electrocautery operators.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of EMI.
Time Frame: up to 90 days
Percentage of patients with EMI, defined as oversensing on atrial or ventricular electrograms during electrocautery.
up to 90 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of pacing inhibition in pacemaker dependent patients with procedures > 6 inches from device.
Time Frame: up to 90 days
Percentage of patients with pacing inhibition recorded intraoperative or on postoperative electrograms during time of electrocautery.
up to 90 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of device reset.
Time Frame: up to 90 days
Percentage of total patients enrolled with device reset requiring reprogramming on their first postoperative interrogation. Either immediately postoperative for reprogramming group, in office or remote for all others.
up to 90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Janet Gifford, MSN, NP, Edward Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

January 30, 2014

First Submitted That Met QC Criteria

January 31, 2014

First Posted (Estimate)

February 3, 2014

Study Record Updates

Last Update Posted (Actual)

July 28, 2017

Last Update Submitted That Met QC Criteria

July 26, 2017

Last Verified

July 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • ICDON2013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Subscribe